Synlogic Inc SYBX

NAS: SYBX | ISIN: US87166L1008 30/04/2025

1,140 USD (-0,87%)

(-0,87%) 30/04/2025

Grafiek Synlogic Inc

Grafiek Synlogic Inc

1 dag1d -0,87%
1 week1w -1,72%
1 maand1m -6,56%
3 maanden3m -13,64%
6 maanden6m -21,92%
1 jaar1j -40,00%
5 jaar5j -43,84%

Synlogic Inc in het nieuws

Toon enkel gratis nieuws

11 augustus 2022 · Synlogic Announces Synthetic Biotic for Gout Developed in Partnership with Ginkgo Bioworks · Persbericht

23 november 2021 · Synlogic Presents Data Demonstrating Reductions in Plasma Phenylalanine Levels in Patients with Phenylketonuria Treated with SYNB1618 · Persbericht

10 november 2021 · Synlogic Reports Third Quarter Financial Results and Provides Business Update · Persbericht

10 november 2021 · Synlogic Announces Presentation of Phenylketonuria Data at 14th International Congress of Inborn Errors of Metabolism Meeting · Persbericht

9 november 2021 · Synlogic and Ginkgo Bioworks Announce Investigational Synthetic Biotic Medicine for the Treatment of Homocystinuria · Persbericht

2 november 2021 · Synlogic Announces Third Quarter 2021 Conference Call & Participation in Upcoming Banking Conference · Persbericht

28 oktober 2021 · Synlogic Announces Nature Communications Publication Highlighting Use of Synthetic Biotic Platform to Optimize Therapies for Phenylketonuria · Persbericht

15 oktober 2021 · Synlogic Presents Data on Hyperoxaluria Program at American Society of Nephrology Kidney Week 2021 · Persbericht

12 oktober 2021 · Synlogic Announces Nature Publication Demonstrating Novel Application of Synthetic Biotic Platform · Persbericht

27 september 2021 · Synlogic Appoints Molly Harper as Chief Business Officer · Persbericht

Profiel Synlogic Inc

Fabricage van farmaceutische preparaten

Gezondheidstechnologie

Website: www.synlogictx.com

Hoofdzetel: Cambridge, Massachusetts Verenigde Staten

CEO: Aoife Brennan

Werknemers: 107

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe